Trelagliptin succinate T2296
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Trelagliptin(SYR-472) is a long-acting inhibitor of dipeptidyl peptidase-4 (DPP-4), being developed for the treatment of type 2 diabetes (T2D).
CAS nr:
1029877-94-8
Purity:
98%
Molecular Weight:
475,47
SMILES:
Cn1c(=O)cc(n(c1=O)Cc1c(ccc(c1)F)C#N)N1CCC[C@H](C1)N.C(CC(=O)O)C(=O)O
Formula:
C22H26FN5O6
Pathway:
Proteases/Proteasome,Proteases/Proteasome,Ubiquitination
Target:
DPP-4,Proteasome,Proteasome
